Smith & Nephew (SNN) Stock
NEW YORK STOCK EXCHANGE, INC. · SNN
27.69
Fundamentals
Market cap
$11.53B
Price / Earnings ratio
19.4x
Price / Sales ratio
2.0x
Price / Book ratio
2.3x
Return on assets
0.1%
Ex-Dividend date
27 Mar 2026
Last payment date
N/A
Dividend amount
$0.00
Dividend yield
2.8%
Debt / Equity ratio
N/A
Latest news
About Smith & Nephew
Smith+Nephew is a portfolio medical technology business that exists to restore people’s bodies and their self-belief by using technology to take the limits off living. We call this purpose ‘Life Unlimited’. Our employees deliver this mission every day, making a difference to patients’ lives through the excellence of our product portfolio, and the invention and application of new technologies across our three global franchises of Orthopaedics, Sports Medicine & ENT and Advanced Wound Management.
SectorHealthcare
IndustryMedical Devices
Employees17,000
CEODr. Deepak S. Nath Ph.D.
IPO DateNov 16, 1999
HeadquartersWatford, United Kingdom
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Dr. Deepak S. Nath Ph.D. | CEO & Director | 1972 |
| Mr. John Terence Rogers | Chief Financial Officer | 1969 |
| Mr. Paul Connolly | President of Global Operations | 1968 |
| Emily Heaven | Head of Investor Relations | — |
| Ms. Helen Barraclough | Group General Counsel & Company Secretary | 1979 |
| Ms. Alison Parkes | Chief Compliance Officer & Compliance APAC | 1972 |
| Mr. Charles Reynolds | Head of Corporate Communication | — |
| Dr. Ajay Dhankhar Ph.D. | Chief Corporate Development & Strategy Officer | 1971 |
| Ms. Elga Lohler | Chief Human Resources Officer | 1968 |
| Dr. Vasant Padmanabhan Ph.D. | President Research & Development, ENT and Emerging Markets | 1967 |
Fundamentals
Valuation
Market cap$11.53B
Price-to-sales ratio1.96
Price-to-book value2.33
Price-earnings ratio19.40
Return on Equity12.00%
Return on Sales0.15%
Return on Assets0.06%
PEG ratio1.06
Earnings Per Share
Earnings Per Share$1.48
Income Statement
Average volume1,912,620
EBITDA$1.49B
1 year high (52w)$37.51
1 year low (52w)$27.23
Dividend
Ex dividend date27 Mar 2026
Dividend amount$0.00
Dividend yield2.78%
Last payment dateN/A
Dividend yield (TTM)N/A
Next earnings reportN/A
Solvency
Debt-to-equity ratioN/A



